AMRX
Price
$7.83
Change
+$0.01 (+0.13%)
Updated
Aug 1 closing price
Capitalization
1.87B
3 days until earnings call
ORGO
Price
$4.51
Change
-$0.11 (-2.38%)
Updated
Aug 1 closing price
Capitalization
374.78M
5 days until earnings call
Interact to see
Advertisement

AMRX vs ORGO

Header iconAMRX vs ORGO Comparison
Open Charts AMRX vs ORGOBanner chart's image
Amneal Pharmaceuticals
Price$7.83
Change+$0.01 (+0.13%)
Volume$1.51M
Capitalization1.87B
Organogenesis Holdings
Price$4.51
Change-$0.11 (-2.38%)
Volume$1.55M
Capitalization374.78M
AMRX vs ORGO Comparison Chart in %
Loading...
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMRX vs. ORGO commentary
Aug 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMRX is a StrongBuy and ORGO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 02, 2025
Stock price -- (AMRX: $7.83 vs. ORGO: $4.51)
Brand notoriety: AMRX and ORGO are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AMRX: 96% vs. ORGO: 167%
Market capitalization -- AMRX: $1.87B vs. ORGO: $374.78M
AMRX [@Pharmaceuticals: Other] is valued at $1.87B. ORGO’s [@Pharmaceuticals: Other] market capitalization is $374.78M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMRX’s FA Score shows that 1 FA rating(s) are green whileORGO’s FA Score has 1 green FA rating(s).

  • AMRX’s FA Score: 1 green, 4 red.
  • ORGO’s FA Score: 1 green, 4 red.
According to our system of comparison, ORGO is a better buy in the long-term than AMRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMRX’s TA Score shows that 4 TA indicator(s) are bullish while ORGO’s TA Score has 3 bullish TA indicator(s).

  • AMRX’s TA Score: 4 bullish, 5 bearish.
  • ORGO’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, AMRX is a better buy in the short-term than ORGO.

Price Growth

AMRX (@Pharmaceuticals: Other) experienced а -2.85% price change this week, while ORGO (@Pharmaceuticals: Other) price change was -10.34% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -2.01%. For the same industry, the average monthly price growth was +5.21%, and the average quarterly price growth was +81.83%.

Reported Earning Dates

AMRX is expected to report earnings on Nov 07, 2025.

ORGO is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-2.01% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMRX($1.87B) has a higher market cap than ORGO($375M). AMRX has higher P/E ratio than ORGO: AMRX (90.00) vs ORGO (70.25). ORGO YTD gains are higher at: 40.938 vs. AMRX (-1.136). AMRX has higher annual earnings (EBITDA): 400M vs. ORGO (36M). ORGO has more cash in the bank: 104M vs. AMRX (91.5M). ORGO has less debt than AMRX: ORGO (119M) vs AMRX (2.75B). AMRX has higher revenues than ORGO: AMRX (2.39B) vs ORGO (433M).
AMRXORGOAMRX / ORGO
Capitalization1.87B375M499%
EBITDA400M36M1,111%
Gain YTD-1.13640.938-3%
P/E Ratio90.0070.25128%
Revenue2.39B433M553%
Total Cash91.5M104M88%
Total Debt2.75B119M2,312%
FUNDAMENTALS RATINGS
AMRX vs ORGO: Fundamental Ratings
AMRX
ORGO
OUTLOOK RATING
1..100
6374
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
71
Overvalued
PROFIT vs RISK RATING
1..100
6194
SMR RATING
1..100
9891
PRICE GROWTH RATING
1..100
5940
P/E GROWTH RATING
1..100
259
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ORGO's Valuation (71) in the Financial Conglomerates industry is in the same range as AMRX (92) in the Pharmaceuticals Major industry. This means that ORGO’s stock grew similarly to AMRX’s over the last 12 months.

AMRX's Profit vs Risk Rating (61) in the Pharmaceuticals Major industry is somewhat better than the same rating for ORGO (94) in the Financial Conglomerates industry. This means that AMRX’s stock grew somewhat faster than ORGO’s over the last 12 months.

ORGO's SMR Rating (91) in the Financial Conglomerates industry is in the same range as AMRX (98) in the Pharmaceuticals Major industry. This means that ORGO’s stock grew similarly to AMRX’s over the last 12 months.

ORGO's Price Growth Rating (40) in the Financial Conglomerates industry is in the same range as AMRX (59) in the Pharmaceuticals Major industry. This means that ORGO’s stock grew similarly to AMRX’s over the last 12 months.

ORGO's P/E Growth Rating (9) in the Financial Conglomerates industry is in the same range as AMRX (25) in the Pharmaceuticals Major industry. This means that ORGO’s stock grew similarly to AMRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMRXORGO
RSI
ODDS (%)
Bearish Trend 1 day ago
67%
Bearish Trend 3 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 3 days ago
85%
Momentum
ODDS (%)
Bearish Trend 1 day ago
75%
N/A
MACD
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 3 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
74%
Bearish Trend 3 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
71%
Bullish Trend 3 days ago
79%
Advances
ODDS (%)
Bullish Trend 6 days ago
80%
Bullish Trend 11 days ago
79%
Declines
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 3 days ago
84%
Aroon
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 3 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HGIFX56.90N/A
N/A
Hartford Core Equity F
HGHAX31.93N/A
N/A
Hartford Healthcare A
TWADX8.11N/A
N/A
American Century Value A
NOIEX18.10N/A
N/A
Northern Income Equity
LFFLX14.82N/A
N/A
Lord Abbett Focused Large Cap Value F

AMRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMRX has been loosely correlated with PAHC. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if AMRX jumps, then PAHC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMRX
1D Price
Change %
AMRX100%
+0.13%
PAHC - AMRX
47%
Loosely correlated
-1.47%
HROW - AMRX
46%
Loosely correlated
-1.67%
VTRS - AMRX
43%
Loosely correlated
+0.80%
AMPH - AMRX
40%
Loosely correlated
+1.24%
ZTS - AMRX
39%
Loosely correlated
+1.09%
More